Keyphrases
COVID-19
100%
Alzheimer's Disease
69%
Confidence Interval
65%
Older Adults
60%
Lung Transplantation
45%
United States
44%
Sepsis
43%
Virus
43%
Parkinson's Disease
40%
Risk Factors
39%
West Nile Virus
33%
Lung
32%
T Cells
30%
Odds Ratio
29%
AIDS/HIV
28%
Emergency Department
28%
Macrophages
28%
Dendritic Cells
28%
Monoclonal Antibody
27%
Cerebrospinal Fluid
26%
Heart Failure
25%
Clinical Trials
25%
Randomized Controlled Trial
25%
Inflammation
23%
Clinical Outcomes
22%
Comorbidity
21%
Gene Expression
20%
Pediatric
20%
Antibiotics
20%
Immune Response
20%
People Living with HIV (PLHIV)
20%
West Nile Virus Infection
20%
High Risk
20%
Interferon-α (IFN-α)
19%
St. Louis
19%
Intensive Care Unit
19%
Transcription Factor
19%
Antiretroviral Therapy
18%
COVID-19 Pandemic
18%
Hospitalization
18%
Central Nervous System
18%
Lymphatic Filariasis
17%
Epitope
17%
Randomized Clinical Trial
17%
Head-and-neck Cancer
17%
Epidemiology
17%
CD8+ T Cells
17%
Meta-analysis
17%
Aging
17%
Vaccination
16%
Placebo
16%
Influenza Virus
16%
Zika Virus
15%
Vesicular Stomatitis Virus
15%
Monocytes
15%
Viral Infection
15%
Missouri
15%
Natural Killer Cells
15%
Mouse Model
15%
Cardiovascular Disease
15%
Innate Immune Response
15%
Viral
15%
Asthma
15%
Kidney
14%
B Cells
14%
Infectious Diseases
14%
Dengue Virus
14%
Quality of Life
14%
Hazard Ratio
14%
Apoptosis
14%
Genome-wide Association Study
14%
HIV Patients
14%
Adjusted Odds Ratio
14%
Late-life Depression
13%
Flavivirus
13%
Staphylococcus Aureus
13%
Transplantation
13%
Disease Severity
13%
Acute Respiratory Distress Syndrome
13%
Neutralizing Antibodies
13%
Tuberculosis
13%
Type 1 Diabetes Mellitus (T1DM)
13%
Surgical Site Infection
12%
Cognitive Impairment
12%
Neutrophils
12%
Depressive Symptoms
12%
Major Depressive Disorder
12%
Chikungunya Virus (CHIKV)
12%
Clinically Significant
12%
Mycobacterium Tuberculosis (M. tb)
12%
Mass Drug Administration
12%
Genotype
12%
Older Patients
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
11%
Adverse Events
11%
Antibody Response
11%
Acute Rejection
11%
Pediatric Patients
11%
Influenza
11%
Clostridium Difficile Infection
11%
Medicine and Dentistry
Infection
86%
Disease
82%
COVID-19
61%
Human Immunodeficiency Virus
46%
Injury
42%
Severe Acute Respiratory Syndrome Coronavirus 2
41%
Pediatrics
40%
Lung Transplantation
36%
Congestive Heart Failure
34%
Lung
33%
Alzheimer's Disease
33%
Sepsis
32%
Odds Ratio
28%
Diagnosis
26%
Clinician
25%
Emergency Department
25%
Prevalence
23%
Clinical Trial
22%
Randomized Controlled Trial
22%
Intensive Care Unit
22%
Drug Therapy
21%
Malignant Neoplasm
20%
Biological Marker
20%
Comorbidity
19%
Systematic Review
18%
Cohort Effect
17%
Quality of Life
17%
Health Care Cost
17%
Bleeding
16%
Pathogen
16%
Transplantation
15%
Hazard Ratio
14%
Placebo
14%
Adverse Event
14%
Head and Neck Cancer
14%
Cardiovascular Disease
14%
Antibiotics
14%
Apoplexy
13%
Lymphatic Filariasis
13%
Cohort Analysis
13%
Randomized Clinical Trial
13%
Diabetes Mellitus
13%
Programmed Cell Death
13%
Diabetes
12%
Immunity
12%
Logistic Regression Analysis
12%
Bloodstream Infection
12%
Surgical Infection
12%
Meta-Analysis
12%
Virus Infection
12%
Health Care
12%
T Cell
12%
Macrophage
12%
Adolescence
12%
Intensive Care
11%
Neoplasm
11%
Surgery
11%
Antiinfective Agent
11%
Messenger RNA
11%
Tertiary Care
11%
Allograft
11%
Medicine
11%
Amyloid Protein
11%
Antiretroviral Therapy
11%
Observational Study
11%
Receptor
11%
Cardiovascular System
11%
Tau
10%
Left Ventricular Assist Device
10%
Outpatient
9%
Platelet
9%
Magnetic Resonance Imaging
9%
Asthma
9%
Neuropathy
9%
Mental Health
9%
Drug Administration
9%
Cerebrospinal Fluid
9%
Immune Response
9%
Public Health
9%
Retrospective Cohort Study
9%
In Vitro
9%
Epithelial Cell
9%
Gut
9%
Parkinson's Disease
8%
Immunosuppressive Treatment
8%
Acute Respiratory Distress Syndrome
8%
Human Immunodeficiency Virus Infection
8%
Gene Expression
8%
Central Nervous System
8%
Recurrent Disease
8%
Pediatrics Patient
8%
Serositis
8%
Cytomegalovirus
8%
Antivirus Agent
8%
Positron Emission Tomography
8%
Overall Survival
8%
Combination Therapy
7%
Patient Care
7%
Venous Thromboembolism
7%
Bronchiolitis Obliterans
7%